HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

João B Calixto Selected Research

cinnamaldehyde (cinnamic aldehyde)

1/2020Corrigendum: Cinnamaldehyde Inhibits Staphylococcus aureus Virulence Factors and Protects against Infection in a Galleria mellonella Model.
4/2019Topical Application of Cinnamaldehyde Promotes Faster Healing of Skin Wounds Infected with Pseudomonas aeruginosa.
2/2017The transient receptor potential ankyrin-1 mediates mechanical hyperalgesia induced by the activation of B1 receptor in mice.
1/2016Cinnamaldehyde Inhibits Staphylococcus aureus Virulence Factors and Protects against Infection in a Galleria mellonella Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


João B Calixto Research Topics

Disease

31Inflammation (Inflammations)
01/2018 - 07/2000
29Hyperalgesia
01/2021 - 10/2002
26Pain (Aches)
01/2021 - 07/2000
16Neuralgia (Stump Neuralgia)
06/2019 - 10/2002
13Edema (Dropsy)
10/2017 - 11/2004
11Colitis
01/2016 - 06/2007
9Neoplasms (Cancer)
01/2020 - 02/2006
7Chronic Pain
01/2021 - 10/2002
7Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2016 - 02/2004
6Necrosis
06/2019 - 05/2003
6Alzheimer Disease (Alzheimer's Disease)
01/2017 - 05/2007
5Cognitive Dysfunction
01/2020 - 03/2010
5Hypersensitivity (Allergy)
06/2019 - 04/2009
5Neuroinflammatory Diseases
01/2017 - 10/2009
5Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2017 - 01/2011
4Peripheral Nervous System Diseases (PNS Diseases)
01/2020 - 09/2011
4Infections
01/2020 - 09/2009
4Body Weight (Weight, Body)
11/2013 - 08/2011
4Pleurisy (Pleuritis)
03/2007 - 02/2002
3Glioma (Gliomas)
10/2015 - 06/2012
3Cystitis
01/2014 - 12/2010
3Asthma (Bronchial Asthma)
08/2008 - 02/2004
3Visceral Pain
02/2006 - 04/2005
2Brain Diseases (Brain Disorder)
01/2020 - 05/2010
2Multiple Sclerosis
01/2017 - 02/2012
2Weight Loss (Weight Reduction)
01/2017 - 01/2016
2Memory Disorders (Memory Loss)
01/2017 - 02/2007

Drug/Important Bio-Agent (IBA)

22KininsIBA
01/2020 - 07/2000
14Freund's AdjuvantIBA
10/2017 - 10/2002
12BradykininIBA
01/2021 - 12/2002
12CarrageenanIBA
09/2012 - 02/2002
9Pharmaceutical PreparationsIBA
12/2015 - 08/2004
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2012 - 05/2003
8Peptides (Polypeptides)IBA
01/2017 - 11/2006
8Proteins (Proteins, Gene)FDA Link
10/2015 - 02/2006
7icatibantIBA
06/2019 - 12/2002
7TriterpenesIBA
07/2013 - 10/2002
7Peroxidase (Myeloperoxidase)IBA
07/2013 - 02/2004
7Capsaicin (Zostrix)FDA Link
04/2010 - 01/2003
6ProstaglandinsIBA
11/2017 - 02/2004
6SB 225002IBA
04/2014 - 10/2008
6Dextran SulfateIBA
11/2013 - 01/2011
62,5-dichloro-4-bromophenol (B 2)IBA
12/2012 - 12/2002
5CytokinesIBA
01/2018 - 02/2004
5ChemokinesIBA
04/2014 - 04/2009
5Gabapentin (Neurontin)FDA LinkGeneric
04/2014 - 10/2002
5Interleukin-6 (Interleukin 6)IBA
10/2013 - 02/2002
5Indomethacin (Indometacin)FDA LinkGeneric
01/2013 - 09/2006
5Amyloid beta-PeptidesIBA
05/2010 - 02/2007
4cinnamaldehyde (cinnamic aldehyde)FDA Link
01/2020 - 01/2016
4Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 09/2011
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2014 - 12/2010
4Phosphotransferases (Kinase)IBA
11/2013 - 02/2004
4sym-trinitrobenzeneIBA
10/2013 - 10/2008
4Sulfonic AcidsIBA
10/2013 - 10/2008
4eupholIBA
01/2013 - 01/2011
4Celecoxib (Celebrex)FDA Link
01/2013 - 08/2004
4Morphine (MS Contin)FDA LinkGeneric
11/2010 - 01/2003
4Glutamic Acid (Glutamate)FDA Link
11/2006 - 01/2002
3Type I Tumor Necrosis Factor ReceptorsIBA
06/2019 - 11/2010
3Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2019 - 02/2004
3Analgesics (Analgesic Drugs)IBA
01/2018 - 08/2004
3caryophylleneIBA
10/2017 - 03/2007
32- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
02/2017 - 03/2010
3Protein Kinase CIBA
02/2017 - 08/2006
3AnkyrinsIBA
02/2017 - 04/2013
3Type C PhospholipasesIBA
02/2017 - 08/2006
3LipidsIBA
08/2016 - 09/2006
3Docosahexaenoic AcidsIBA
08/2016 - 08/2011
3Dextrans (Dextran)FDA Link
01/2016 - 10/2012
3SesquiterpenesIBA
12/2015 - 10/2009
3polygodialIBA
12/2015 - 03/2004
3Chemokine ReceptorsIBA
01/2014 - 02/2004
3Messenger RNA (mRNA)IBA
10/2013 - 09/2009
3Cannabinoid Receptors (Cannabinoid Receptor)IBA
07/2013 - 03/2011
3CannabinoidsIBA
07/2013 - 01/2011
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2013 - 08/2004
3Interleukin-10 (Interleukin 10)IBA
12/2012 - 02/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2012 - 10/2009
3Pertussis ToxinIBA
01/2011 - 01/2003
32- ((3- (1,3- benzodioxol- 5- yl)- 3- (((6- methoxy- 2- naphthyl)sulfonyl)amino)propanoyl)amino)- 3- (4- ((2,6- dimethylpiperidinyl)methyl)phenyl)- N- isopropyl- N- methylpropanamideIBA
12/2010 - 09/2006
3Thalidomide (Thalomid)FDA Link
11/2010 - 10/2005
3LipopolysaccharidesIBA
04/2010 - 05/2003
3Dinoprostone (PGE2)FDA Link
09/2007 - 08/2006
3Opioid Analgesics (Opioids)IBA
11/2006 - 08/2004
3Histamine (Histamine Dihydrochloride)FDA Link
09/2006 - 02/2003
2Bradykinin Receptors (Bradykinin Receptor)IBA
01/2021 - 01/2017
2Virulence Factors (Pathogenicity Factors)IBA
01/2020 - 01/2016
2FR 173657IBA
01/2020 - 01/2003
2Interleukin-17 (Interleukin 17)IBA
04/2019 - 01/2017
2diacereinIBA
10/2017 - 12/2005
2Matrix Metalloproteinases (MMPs)IBA
10/2017 - 02/2004
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2017 - 02/2004
2Interleukin-4 (Interleukin 4)IBA
01/2017 - 12/2012
2Neuroprotective AgentsIBA
01/2017 - 11/2010
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
08/2016 - 08/2011

Therapy/Procedure

8Ligation
04/2014 - 10/2002
7Therapeutics
01/2017 - 12/2006
6Oral Administration
11/2013 - 10/2002
5Drug Therapy (Chemotherapy)
01/2020 - 12/2010